AgenT-797 is a scalable, off-the-shelf therapy that retains potent cytotoxicity after cryopreservation. Patients with LBCL received prophylactic anakinra to reduce the risk of cytokine release syndrome following CAR-T. Penpulimab demonstrated a good safety profile in patients with relapsed/refractory classical Hodgkin lymphoma.